CK Life Sciences International Holdings (FRA:LSI) Days Sales Outstanding : 64.91 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is CK Life Sciences International Holdings Days Sales Outstanding?

CK Life Sciences International Holdings's average Accounts Receivable for the six months ended in Dec. 2023 was €114.6 Mil. CK Life Sciences International Holdings's Revenue for the six months ended in Dec. 2023 was €322.1 Mil. Hence, CK Life Sciences International Holdings's Days Sales Outstanding for the six months ended in Dec. 2023 was 64.91.

The historical rank and industry rank for CK Life Sciences International Holdings's Days Sales Outstanding or its related term are showing as below:

FRA:LSI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 54.26 Med: 70.46 Max: 78
Current: 66.07

During the past 13 years, CK Life Sciences International Holdings's highest Days Sales Outstanding was 78.00. The lowest was 54.26. And the median was 70.46.

FRA:LSI's Days Sales Outstanding is ranked better than
54.26% of 892 companies
in the Biotechnology industry
Industry Median: 72.245 vs FRA:LSI: 66.07

CK Life Sciences International Holdings's Days Sales Outstanding increased from Dec. 2022 (61.98) to Dec. 2023 (64.91).

CK Life Sciences International Holdings Days Sales Outstanding Historical Data

The historical data trend for CK Life Sciences International Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CK Life Sciences International Holdings Days Sales Outstanding Chart

CK Life Sciences International Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

71.92

65.92

52.57

59.89

64.01

CK Life Sciences International Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															58.53	61.57	61.98	71.61	64.91

Competitive Comparison of CK Life Sciences International Holdings's Days Sales Outstanding

For the Biotechnology subindustry, CK Life Sciences International Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CK Life Sciences International Holdings's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where CK Life Sciences International Holdings's Days Sales Outstanding falls into.

CK Life Sciences International Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

CK Life Sciences International Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (114.273	+	104.934)	/	2 )	/	624.977	*	365
=	109.6035					/	624.977	*	365
=	64.01

CK Life Sciences International Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (124.236	+	104.934)	/	2 )	/	322.145	*	365 / 2
=	114.585					/	322.145	*	365 / 2
=	64.91

CK Life Sciences International Holdings (FRA:LSI) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

CK Life Sciences International Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of CK Life Sciences International Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

CK Life Sciences International Holdings (FRA:LSI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CK Life Sciences International Holdings Inc (FRA:LSI) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

00775:Hong Kong

Address

2 Dai Fu Street, Tai Po Industrial Estate, Tai Po, Hong Kong, HKG

Website

https://www.ck-lifesciences.com

CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The company operates three core businesses, including agriculture, nutraceutical, and pharmaceutical. Its overall product portfolio involves a presence that spans North America and the Asia Pacific. The company uses mergers and acquisitions when it identifies attractive market opportunities.